Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Ying

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Clinical Epigenetics|February 21, 2023
Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasmsAnkit Chhoda, Anup Sharma, Bethsebie Sailo, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers-A Report from the Western Canadian Gastrointestinal Cancer Consensus ConferenceKaren Mulder, Howard Lim, Deepti Ravi, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Report from the Western Canadian Gastrointestinal Cancer Consensus Conference Virtual Education Series-Transition from Local to System Therapy and Optimal Sequencing of Systemic Therapy for HCCAdnan Zaidi, Shahid Ahmed, Shahida Ahmed, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Report from the 26th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Hepatocellular and Biliary Tract Cancer, Saskatoon, Saskatchewan, 17-18 October 2024Deepti Ravi, Shahid Ahmed, Blaire Anderson, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus ConferenceShahid Ahmed, Nicholas Bosma, Michael Moser, et al.
Clinical Genitourinary Cancer|December 17, 2024
Real-world Clinical Outcomes and Prognostic Factors in Neuroendocrine Prostate CancerRichard Gagnon, Ealia Khosh Kish, Sarah Cook, et al.
BJUI Compass|August 11, 2022
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based studyShawn Malone, Christopher J D Wallis, Richard Lee-Ying, et al.
Current Oncology (Toronto, Ont.)|January 4, 2020
Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018D M Le, S Ahmed, S Ahmed, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal CancerHoward Lim, Aswin George Abraham, Shahid Ahmed, et al.
JAMA Network Open|July 22, 2021
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line TherapyEdoardo Francini, Francesco Montagnani, Pier Vitale Nuzzo, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Clinical Epigenetics|February 21, 2023
Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasmsAnkit Chhoda, Anup Sharma, Bethsebie Sailo, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers-A Report from the Western Canadian Gastrointestinal Cancer Consensus ConferenceKaren Mulder, Howard Lim, Deepti Ravi, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Report from the Western Canadian Gastrointestinal Cancer Consensus Conference Virtual Education Series-Transition from Local to System Therapy and Optimal Sequencing of Systemic Therapy for HCCAdnan Zaidi, Shahid Ahmed, Shahida Ahmed, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Report from the 26th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Hepatocellular and Biliary Tract Cancer, Saskatoon, Saskatchewan, 17-18 October 2024Deepti Ravi, Shahid Ahmed, Blaire Anderson, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus ConferenceShahid Ahmed, Nicholas Bosma, Michael Moser, et al.
Clinical Genitourinary Cancer|December 17, 2024
Real-world Clinical Outcomes and Prognostic Factors in Neuroendocrine Prostate CancerRichard Gagnon, Ealia Khosh Kish, Sarah Cook, et al.
BJUI Compass|August 11, 2022
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based studyShawn Malone, Christopher J D Wallis, Richard Lee-Ying, et al.
Current Oncology (Toronto, Ont.)|January 4, 2020
Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018D M Le, S Ahmed, S Ahmed, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal CancerHoward Lim, Aswin George Abraham, Shahid Ahmed, et al.
JAMA Network Open|July 22, 2021
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line TherapyEdoardo Francini, Francesco Montagnani, Pier Vitale Nuzzo, et al.
Pageof 14